Production assistance for cellular therapies (PACT)- cell processing facilities cell manufacturing and process development services for PCT0031-02: GMP production of ipsc line and scale-up of…
Ended Awarded Last action
- Contract number
- 75N92020F00001
- Awardee
-
University Of Miami UEI F8THLJQSAF93 Part of University Of Miami
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,016,452
Award facts
- Opportunity
-
- 75N92019R0070 Solicitation number
- Contract value 100% obligated
- $1,016,451.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- South Miami, FL 33146, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$725 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,017,177 |
About this award
This federal contract award is for the Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities project, with the National Heart Lung and Blood Institute as the funding agency. The prime contractor is the University of Miami, a private non-profit research university that conducts a wide range of biomedical and healthcare research funded by federal agencies. The $1,016,451.61 contract provides cell manufacturing and process development services for induced pluripotent stem cell line production and scale-up of a cardiac progenitor cell product. This award is a delivery order under the PACT-CPF Indefinite Delivery Contract, which allows the National Heart Lung and Blood Institute to issue task orders to the University of Miami for specialized cell processing and manufacturing services. The contract does not have a set-aside designation, indicating it was competed on a full and open basis.
Description
Production assistance for cellular therapies (PACT)- cell processing facilities cell manufacturing and process development services for PCT0031-02: GMP production of ipsc line and scale-up of cardiac progenitor cell product
Quick answers
Who was awarded contract 75N92020F00001?
75N92020F00001 was awarded to University Of Miami by National Heart Lung and Blood Institute (National Institutes of Health) on December 10, 2019.
How much is contract 75N92020F00001 worth?
The government has obligated $1,016,452 on 75N92020F00001.
Is contract 75N92020F00001 an order under another contract?
Yes. 75N92020F00001 is a delivery order under HHSN268201600012I, an indefinite delivery contract, on Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract 75N92020F00001 competed?
The extent of competition for 75N92020F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award